Bert Kinsey

Bert Kinsey is a seasoned professional in the fields of research and finance, currently serving as a Principal Research Analyst at Eventide Asset Management since January 2023. Prior experience includes roles as Principal and Senior Associate at Pappas Capital from July 2020 to January 2023, as well as Senior Associate for Biotechnology Equity Research at RBC Capital Markets from May 2018 to July 2020. Bert Kinsey also held academic positions at the University of Virginia School of Medicine as an Associate Professor of Medicine and previously as an Assistant Professor, where research focused on the therapeutic role of regulatory T cells in acute kidney injury. Bert's early career included a postdoctoral fellowship at the University of Virginia Health System. Bert Kinsey earned a Doctor of Pharmacy (Pharm.D.) and a Doctor of Philosophy (Ph.D.) in Toxicology and Physiology from the Medical University of South Carolina, completing these degrees between 2000 and 2007.